OREANDA-NEWS. Veles Capital Investment Group was named Investor Awards 2013 laureate in “Private Equity and Venture investments: deal of the year” nomination. Veles Capital was financial and legal adviser of the Venture Investments & Yield Management LLP (VIYM) and Syktyvkar Tissue Group (STG) deal.

The deal is the first step of the STG strategic program of long-term development (2013 – 2023). The company is planning to diversify the activity by developing the new manufacturing facilities and thus expanding on the new market of tissue products for professional usage.

“We are glad to realize that our work was rewarded. Veles Capital has been the company’s adviser during many years and we think that it has a good potential. By attracting the strategic investor STG may shift the gear and we are happy to be part of this process”, - said Mikhail Zak, Veles Capital Investment Group’s Managing Director.

Veles Capital Investment Group is part of Veles Capital group, which renders services on financial markets for wealthy private and corporate investors since 1995. Veles Capital Investment Group specializes in private equity, financial consulting, M&A, IR, due diligence etc. Nowadays company manages 10 private equity projects worth USD 500 mln.

Syktyvkar Tissue Group is one of the largest manufacturer and supplier of tissue products in Russia. The company is one of the 4 leaders of the market with 20% market share. STG is owner of “Veiro” brand. The company’s part of sales exposure in retail is estimated as 20% in 2012 and may increase to 30% by the end of 2013.